ReviewBioactive materials2026
Harnessing nature's blueprint: Unlocking the potential of subcellular structure membrane-coated nanosystems for precision medicine.
Review in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bioinspired Artificial Bioenergetic Organelles: Design Principles, Nanofabrication and Therapeutic Translation.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Recent Advances on Extracellular Vesicles: A Natural Nanomaterial for Biomedical Application.Biomimetics (Basel, Switzerland) · 2026Review
- Gold Nanoplatforms for Phenotypic Reprogramming and Closed-Loop Theranostics of Cancer Stem Cells.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the intricate tapestry of life, subcellular structures stand out as the fundamental building blocks that orchestrate the complexities of cellular function. Collectively, they govern the course of events at the subcellular level and cooperate to maintain cellular physiological functions and homeostasis and they are present in all eukaryotic cells, from the unicellular organisms to the more complex ones. Herein, we aim to explore the cutting-edge, bioinspired brunch of nanotechnology focused on the fabrication of biomimetic nanoparticles consisting of a synthetic core coated with the natural membranes deriving from membrane-bound subcellular organelles. Beyond the well-grounded biomedical evidence on the use of membranes derived from cells, exosomes and bacteria, recent insights have unlocked the potential of the nanosystems mimicking the subcellular intricacy for subcellular-oriented medicine. Despite the recent promising results, several challenges remain in the translation of this technology to the clinical settings. The current lack of standardization, challenging industrial scale-up, immunological concerns, as well as demanding regulatory considerations still remains aspects to be analyzed and discussed, in order to fill the current gap between the research and the clinical application.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.